Endocrine Disruption Prevention Act of 2009

H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical Facility Anti-Terrorism Act of 2009 H.R. 5320, Assistance Quality and Affordability Act of 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Act of 2010 H.R. 5820, Toxic Chemicals Safety Act of 2010 H.R. 6087, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides H.R. 4678, Foreign Manufacturers Legal Accountability Act of 2010 H.R. 6273, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to exempt the application of pesticides subject to that Act, when applied in conformance with that Act, from certain permit requirements under the Federal Water Pollution Control Act, and for other purposes H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5088, America's Commitment to Clean Water Act H.R. 2892, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 H.R. 5509, Chesapeake Bay Program Reauthorization and Improvement Act S. 1816, Chesapeake Clean Water and Ecosystem Restoration Act S. 1868, The Chesapeake Clean Water and Ecosystem Act of 2009 S. 519, POPs, LRTAP POPs, and Pic Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act of 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010 S. 3209, The Safe Chemicals Act of 2010 S. 3735, A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides S. 3861, Strengthening Protection for Children and Communities from Disease Clusters Act S. 3834, Representation for Farmers Act

Client expense: $750,621 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE

H.R. 849, Worker Protection Against Combustible Dust Explosions and Fires Act of 2009 H.R. 875, Food Safety Modernization Act of 2009 H.R. 1523, Ban Poisonous Additives Act of 2009 H.R. 2067, Protecting America's Workers Act H.R. 2190, Mercury Pollution Reduction Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5320, Assistance, Quality and Affordability Act of 2010 (endocrine disruption screening program) H.R. 5820, Toxic Chemicals Safety Act of 2010 S. 593, Ban Poisonous Additives Act of 2009 S. 753, BPA-Free Kids Act of 2009 S. 1428, Mercury Pollution Reduction Act S. 2828, Endocrine Disruption Prevention Act of 2009 S. 3209, Safe Chemicals Act of 2010 Kid-Safe Chemicals Act Children's Health Domestic Ban on Asbestos in Products (Exemption for Chlor-Alkali Industry) Phthalates Water Disinfection

Client expense: $1,530,000 · Firm income: Not reported

H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 HR 4190, S 2828, Endocrine Disruption Prevention Act of 2009 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S 3209, Safe Chemicals Act of 2010

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 HR 4190, S 2828, Endocrine Disruption Prevention Act of 2009 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S 3209, Safe Chemicals Act of 2010

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 111th House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 5820 The Safe Chemicals Act of 2010 (Senate version 3209) The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 5786 Safe Cosmetics Act of 2010 (Senate version not yet introduced) The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund provided educational briefings to staff within the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the Presidents Cancer Panel. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.

Toxic Substances Control Act reform (S. 3209 and H.R. 5820); Legislation on endocrine disruptors (H.R. 4190, S. 2828, H.R. 5320, H.R. 5210); Safe Cosmetic Act (H.R. 5786); House investigation into fluids used in hydraulic fracturing ("fracking") process.

Client expense: $290,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

Toxic Substances Control Act - H.R. 5820, Toxic Chemicals Safety Act of 2010 S. 3209, Safe Chemicals Act of 2010 H.R. 4190, Endrocrine Disruption Prevention Act of 2009 H.R. 5320, Assistance, Quality and Affordability Act of 2010

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 849, Worker Protection Against Combustible Dust Explosions and Fires Act of 2009 H.R. 875, Food Safety Modernization Act of 2009 H.R. 1523, Ban Poisonous Additives Act of 2009 H.R. 2067, Protecting America's Workers Act H.R. 2190, Mercury Pollution Reduction Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5320, Assistance, Quality and Affordability Act of 2010 (endocrine disruption screening program) H.R. 5820, Toxic Chemicals Safety Act of 2010 S. 593, Ban Poisonous Additives Act of 2009 S. 753, BPA-Free Kids Act of 2009 S. 1428, Mercury Pollution Reduction Act S. 2828, Endocrine Disruption Prevention Act of 2009 S. 3209, Safe Chemicals Act of 2010 Kid-Safe Chemicals Act Children's Health Domestic Ban on Asbestos in Products (Exemption for Chlor-Alkali Industry) Phthalates Water Disinfection

Client expense: $2,080,000 · Firm income: Not reported

HR 2868, Chemical Facility Anti-Terrorism Act of 2009 Toxic Substances Control Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 HR.5320, Assistance, Quality, and Affordability ACt of 2010. H.R. 4678, Foreign Manufacturers Legal Accountability Act of 2010 S. 1606, Foreign Manufacturers Legal Accountability Act of 2009

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical Facility Anti-Terrorism Act of 2009 H.R. 5320, Assistance Quality and Affordability Act of 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Act 2010 H.R. 5820, Toxic Chemicals Safety Act of 2010 H.R. 6087, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides H.R. 4678, Foreign Manufacturers Legal Accountability Act of 2010 H.R. 6273, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to exempt the application of pesticides subject to that Act, when applied in conformance with that Act, from certain permit requirements under the Federal Water Pollution Control Act, and for other purposes H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5088, America's Commitment to Clean Water Act H.R. 2892, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 1868, The Chesapeake Clean Water and Ecosystem Act of 2009 S. 519, POPs, LRTAP POPs, and Pic Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010 S. 3209, The Safe Chemicals Act of 2010 S. 3735, A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides S. 3861, Strengthening Protection for Children and Communities From Disease Clusters Act S. 3834, Representation for Farmers Act

Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) Continued: Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund has met with staff from various House and Senate offices about future legislation to reform the Estrogenic Substances Screening Program at EPA with the goal of identifying and removing estrogenic compounds in our nations drinking supply that currently increase the risk of breast cancer incidence. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process. S.3209, the Safe Chemicals Act of 2010 (House bill not yet introduced). The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products.

Toxic Substances Control Act H.R. 4190, Endrocrine Disruption Prevention Act of 2009 H.R. 5320, Assistance, Quality and Affordability Act of 2010

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2868, Chemical Facility Anti-Terrorism Act of 2009 Toxic Substances Control Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 HR.5320, Assistance, Quality, and Affordability ACt of 2010.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 849, Worker Protection Against Combustible Dust Explosions and Fires Act of 2009 H.R. 875, Food Safety Modernization Act of 2009 H.R. 1523, Ban Poisonous Additives Act of 2009 H.R. 2067, Protecting America's Workers Act H.R. 2190, Mercury Pollution Reduction Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5320, Assistance, Quality and Affordability Act of 2010 (endocrine disruption screening program) S. 593, Ban Poisonous Additives Act of 2009 S. 753, BPA-Free Kids Act of 2009 S. 1428, Mercury Pollution Reduction Act S. 2828, Endocrine Disruption Prevention Act of 2009 S. 3209, Safe Chemicals Act of 2010 Chemicals Management/Toxic Substances Control Act Modernization Kid-Safe Chemicals Act Children's Health Domestic Ban on Asbestos in Products (Exemption for Chlor-Alkali Industry) Phthalates Water Disinfection

Client expense: $1,790,000 · Firm income: Not reported

Chemical Management/TSCA reform; Endocrine bill/ingredient disclosure. House discussion draft bill and S. 3209, H.R. 4190, S. 2828, H.R. 5320

Client expense: $280,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) Continued: Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund has met with staff from various House and Senate offices about future legislation to reform the Estrogenic Substances Screening Program at EPA with the goal of identifying and removing estrogenic compounds in our nations drinking supply that currently increase the risk of breast cancer incidence. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.

H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical and Water Security Act of 2009 H.R. 4190, The Endocrine Disruption Prevention Act of 2009 H.R. 2996, Department of Interior, Environment, and Related Agencies Appropriations Act 2010 H.R. 2892, Department of Homeland Security Appropriations Act 2010 H.R. 1260, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 519, POPs, LRTAP, POPs, and PIC Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Atriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010

Client expense: $519,731 · Firm income: Not reported

H.R. 849, Worker Protection Against Combustible Dust Explosions and Fires Act of 2009 H.R. 875, Food Safety Modernization Act of 2009 H.R. 1523, Ban Poisonous Additives Act of 2009 H.R. 2067, Protecting America's Workers Act H.R. 2190, Mercury Pollution Reduction Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 S. 593, Ban Poisonous Additives Act of 2009 S. 753, BPA-Free Kids Act of 2009 S. 1428, Mercury Pollution Reduction Act S. 2828, Endocrine Disruption Prevention Act of 2009 Chemicals Management/Toxic Substances Control Act Modernization Kid-Safe Chemicals Act Children's Health Domestic Ban on Asbestos in Products (Exemption for Chlor-Alkali Industry) Phthalates Water Disinfection

Client expense: $2,730,000 · Firm income: Not reported

Toxic Substances Control Act H.R. 4190, Endrocrine Disruption Prevention Act of 2009

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2868, Chemical Facility Anti-Terrorism Act of 2009 Toxic Substances Control Act H.R. 4190, Endocrine Disruption Prevention Act of 2009

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act; Minority Health Disparities (obesity and diabetes); Endocrine Disruptors Issues; H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions H.R.4190, S.2828, Endocrine Disruption Prevention Act of 2009 H.R.4161, Women's Environmental Health and Disease Prevention Act of 2009

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical and Water Security Act of 2009 H.R. 4190, The Endocrine Disruption Prevention Act of 2009 S. 519, POPs, LRTAP POPs, and PIC Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Apporpriations Act, 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Appropriations Act 2010 H.R. 2892, Department of Homeland Security Appropriations Act 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 H.R. 1260, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009

Client expense: $474,161 · Firm income: Not reported

H.R. 849, Worker Protection Against Combustible Dust Explosions and Fires Act of 2009 H.R. 875, Food Safety Modernization Act of 2009 H.R. 1523, Ban Poisonous Additives Act of 2009 H.R. 2065, Mercury Pollution Reduction Act of 2009 H.R. 2067, Protecting America's Workers Act H.R. 2190, Mercury Pollution Reduction Act H.R. 4190, Endocrine Disruption Prevention Act of 2009 S. 593, Ban Poisonous Additives Act of 2009 S. 753, BPA-Free Kids Act of 2009 S. 1428, Mercury Pollution Reduction Act S. 2828, Endocrine Disruption Prevention Act of 2009 Chemicals Management/Toxic Substances Control Act Modernization Kid-Safe Chemicals Act Children's Health Domestic Ban on Asbestos in Products (Exemption for Chlor-Alkali Industry) Phthalates Water Disinfection

Client expense: $2,120,000 · Firm income: Not reported